APA Zitierstil

Dereke, J., Nilsson, C., Strevens, H., Landin-Olsson, M., & Hillman, M. (2016). IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes. Clinical immunology (Orlando, Fla.), 162, 45. https://doi.org/10.1016/j.clim.2015.11.001

Chicago Zitierstil

Dereke, Jonatan, Charlotta Nilsson, Helena Strevens, Mona Landin-Olsson, und Magnus Hillman. "IgG4 Subclass Glutamic Acid Decarboxylase Antibodies (GADA) Are Associated with a Reduced Risk of Developing Type 1 Diabetes as Well as Increased C-peptide Levels in GADA Positive Gestational Diabetes." Clinical Immunology (Orlando, Fla.) 162 (2016): 45. https://dx.doi.org/10.1016/j.clim.2015.11.001.

MLA Zitierstil

Dereke, Jonatan, et al. "IgG4 Subclass Glutamic Acid Decarboxylase Antibodies (GADA) Are Associated with a Reduced Risk of Developing Type 1 Diabetes as Well as Increased C-peptide Levels in GADA Positive Gestational Diabetes." Clinical Immunology (Orlando, Fla.), vol. 162, 2016, p. 45.